Clinical trial

Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined…

NCT00431093 · Organon and Co, Industry · Completed

Key facts

NCT number NCT00431093
Title Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®)
Official title A Multicenter, Randomized, Double-Blind, Double Dummy, Group-Comparative Trial to Compare the Effects of Livial® and Activelle ® on the Vaginal Bleeding Pattern, Vasomotor Complaints, Vaginal Atrophy, QoL and Sexual Function
Acronym TOTAL
Lead sponsor Organon and Co, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Menopause
Intervention type Drug
Interventions tibolone, low-dose estradiol/noresterone
Enrollment 570
Start date Nov 1, 2002
Primary completion Mar 1, 2005
Completion Mar 1, 2005
First posted Feb 5, 2007
Last update posted Feb 3, 2022

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies